Prostate cancer is the second-leading cause of death in American men. However, prostate cancer is curable, thanks to options ...

The doctors of Manipal Hospitals, Dhakuria, came together to emphasise the need for greater awareness about prostate cancer, ...

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess ...

A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.

The ARASAFE study showed significant reductions in grade 3-5 adverse events and grade 3-4 neutropenia/death rates with a 50 mg/m2 biweekly docetaxel regimen. Despite a higher cumulative docetaxel dose ...

Prostate cancer has become a significant health concern among men, being the second leading cause of death in the United States. While the survival rate in men remains high, those who have advanced, ...

Dr. Kelly Stratton answers the most frequently asked questions in prostate cancer regarding risk for recurrence, progression and treatment options. Navigating a prostate cancer diagnosis involves ...

Patients with metastatic castration-resistant prostate cancer who received Lu-177-PSMA-617 (Pluvicto) achieved similar overall survival and had fewer serious adverse events compared to those who ...

Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $130 million in growth capital to Candel Therapeutics, Inc. (Nasdaq: CADL) ( ...

After undergoing proton beam therapy, Ashya is cancer-free, his father said. — -- The parents of a 5-year-old who were briefly jailed after taking him from a British hospital and seeking ...